Physician profile
Santhosh Augustine
NPI 1689663700
$955.89
in general payments reported to CMS, 2019-2025
19 companies · $50.36 in 2025
The $50.36 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.67 · 2020: $83.45 · 2021: $288 · 2022: $196 · 2023: $115 · 2024: $208 · 2025: $50.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.05 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $300.49 | 2021-2024 | |
| Abbvie INC. | $149.64 | 2020-2024 | Viberzi, Linzess |
| Madrigal Pharmaceuticals | $75.11 | 2024-2025 | Resmetirom, Rezdiffra |
| Braintree Laboratories, INC. | $56.94 | 2020-2022 | |
| Ironwood Pharmaceuticals, INC | $46.89 | 2024 | |
| Nestle Healthcare Nutrition INC. | $36.84 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $36.19 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.90 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $32.57 | 2023 | Cimzia |
| Teva Pharmaceuticals USA, INC. | $29.37 | 2021-2023 | Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.18 | 2024 | Trulance |
| Ardelyx, INC. | $21.65 | 2024 | Ibsrela |
| Ambu INC. | $19.30 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $19.27 | 2025 | |
| Daiichi Sankyo INC. | $18.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.49 | 2021 | |
| Qol Medical, LLC | $14.18 | 2022 | |
| Allergan, INC. | $12.96 | 2020 | |
| Phathom Pharmaceuticals, INC. | $9.78 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santhosh Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.